leisure time -WSS

leisure time

author：fashion 2025-10-03 00:38:31 - browse：28

Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the company’s bid to secure Medicare coverage for its pricey blood-based cancer screening test that has been on the market for over a year but is not widely used.

A recently posted lobbying report indicates that, during the fourth quarter of last year, the biotech spent $1.07 million on “issues related to oncology and multi-cancer early detection,” including House and Senate bills that would allow Medicare to cover multi-cancer screening tests. That figure has been rising; during the fourth quarter of 2021, the company spent $470,000 on lobbying. That’s far more than cancer and genetic testing biotechs such as Guardant Health, Myriad Genetics, and Tempus, which spent anywhere from $90,000 to nearly $300,000 on lobbying last quarter.

The growing investment in lobbying elected officials comes at a time when Grail is looking to make its test, Galleri, available to a broader swath of the population. The test, launched in 2021, can detect early signs of more than 50 cancers among people who don’t have symptoms. That’s because cancer cells release bits of DNA into the bloodstream, and Galleri spots telltale modifications to this DNA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Sage considers ways to reduce costs following FDA rejection

leisure time

WSS

Feed a cold, starve a fever? Here’s what science says

With measles on the rise, a personal story of a devastating disease

Data integrity in scientific journals requires "effort" by publishers, institutions

With measles on the rise, a personal story of a devastating disease

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Failure, not just success, should guide future doctors

leisure time

leisure time

focus

ChatGPT in medicine: STAT answers readers' burning questions

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Hepatitis C has a cure — but many Americans still lack access to it

Readers respond to H5N1 and livestock movements, and more

Medicare proposal to cover medical devices draws a mixed reaction

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

How one medical school became remarkably diverse

Solving academic medical centers' existential crisis

Alkermes shareholders re

Military medical care influenced by rank and race, new study finds

hotspot

Data integrity in scientific journals requires "effort" by publishers, institutions

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Data integrity in scientific journals requires "effort" by publishers, institutions

Readout LOUD podcast: Live from STAT Breakthrough Summit West

When prostate cancer spreads, where it goes matters

Trump used to be more articulate. What could explain the change?

explore

hotspot

leisure time

leisure time